The ENDVOC Consortium Calls for Funding, Research and Awareness on Long Covid and Other Post-Acute Infection Syndromes
A recently published document provides a timely update on the epidemiology, burden and policy actions on Long Covid […]
ENDVOC Study Finds Stronger Immune Response to SARS-CoV-2 Infection in People with Long COVID
The study, based on a population cohort in England, measured levels of antibodies to the SARS-CoV-2 virus […]
COVID-19 Vaccination Induces Long-Lasting Antibody B-cell Responses
END-VOC researchers followed a cohort of healthcare workers in Catalonia during three years […]
A Switch to IgG4 Antibodies After COVID-19 Vaccination May Increase the Risk of Breakthrough Infections
For over three years, ENDVOC researchers analysed the quantity and function of different antibody classes in a cohort of healthcare workers who received mRNA vaccine booster doses […]
Symptoms of Long-COVID Can Last Up to Two Years After Infection, Say END-VOC Researchers
Almost one in four people infected with SARS-CoV-2 suffered from long-COVID, according to a population-based cohort study in Catalonia […]
